These findings underscore the need for future studies examining the role of non-BRCA1/2 genes in SBC and CBC to help inform the complex decision-making process that physicians and patients must navigate when results of multigene panel testing are returned for a patient with a new breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.